$ACOR ACORDA THERAPEUTICS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ACORDA THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ACORDA THERAPEUTICS INC for free.

CIK Number: 0001008848
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ACOR
Company Address: 420 SAW MILL RIVER ROAD ARDSLEY 10502

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine) and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.

Market Capitalization: $941.09M
Prev close: $21.20
Average Daily Volume: 596,379
Days Low: $19.95
Year Low: $16.40
Year High: $37.36

ACORDA THERAPEUTICS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Kelley John PDirector00Jun 04 20212 months ago
Randall LorinDirector00shares bought: 11,488 / shares sold: -11,488 HOLDJun 04 20212 months ago

View all ACORDA THERAPEUTICS INC insiders.

ACORDA THERAPEUTICS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 04 2021ACORACORDA THERAPEUTIC ...Randall LorinDirectorOption ExerciseA3.7510,00037,50010,000
Jun 04 2021ACORACORDA THERAPEUTIC ...Kelley John PDirectorOption ExerciseA3.7510,00037,50010,000
Mar 05 2021ACORACORDA THERAPEUTIC ...Sabella Lauren MChief Commercial Of ...GrantA0.0011,125013,7322.6 K to 13.7 K (+426.74 %)
Mar 05 2021ACORACORDA THERAPEUTIC ...COHEN RONPresident and CEOGrantA0.0029,0000135,830106.8 K to 135.8 K (+27.15 %)
Mar 05 2021ACORACORDA THERAPEUTIC ...BLANK BURKHARDCMO and Head of R&DGrantA0.0011,125018,5277.4 K to 18.5 K (+150.30 %)
Nov 12 2020ACORACORDA THERAPEUTIC ...LAWRENCE DAVIDChief, Bus. Ops & P ...Payment of ExerciseF0.861,02488114,95216 K to 15 K (-6.41 %)
Sep 21 2020ACORACORDA THERAPEUTIC ...Sabella Lauren MChief Commercial Of ...GrantA0.003,015015,63912.6 K to 15.6 K (+23.88 %)
Sep 21 2020ACORACORDA THERAPEUTIC ...LAWRENCE DAVIDChief, Bus. Ops & P ...GrantA0.003,015015,97613 K to 16 K (+23.26 %)
Sep 21 2020ACORACORDA THERAPEUTIC ...COHEN RONPresident and CEOGrantA0.008,5430640,980632.4 K to 641 K (+1.35 %)
Sep 21 2020ACORACORDA THERAPEUTIC ...BLANK BURKHARDCMO and Head of R&DGrantA0.003,015044,41041.4 K to 44.4 K (+7.28 %)
Jun 17 2020ACORACORDA THERAPEUTIC ...RAUSCHER STEVEN MDirectorOption ExerciseA0.8515,00012,76815,000
Jun 17 2020ACORACORDA THERAPEUTIC ...STRADER CATHERINE D.DirectorOption ExerciseA0.8515,00012,76815,000
Jun 17 2020ACORACORDA THERAPEUTIC ...Randall LorinDirectorOption ExerciseA0.8515,00012,76815,000
Jun 17 2020ACORACORDA THERAPEUTIC ...PANEM SANDRA PHDDirectorOption ExerciseA0.8515,00012,76815,000
Jun 17 2020ACORACORDA THERAPEUTIC ...Kelley John PDirectorOption ExerciseA0.8515,00012,76815,000

View all ACORDA THERAPEUTICS INC insider transactions.